Company: Johnson and Johnson

Check out which companies are making headlines after-the-bell Wednesday:    Read More

The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop.   Read More

With shares tumbling after Coty, the privately held maker of Beyoncé Knowles perfume, withdrew its hotly contested $10.7 billion takeover offer, Avon Products CEO Sherilyn McCoy needs to prove to investors that a turnaround plan is possible for the beauty products giant.    Read More

Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years. One stock that investors have become less enamored with, however, is Johnson & Johnson.    Read More

There seem to be two camps: invest in bonds or stocks that yield above two percent or take the riskier route of picking stocks that can outgrow this economy.    Read More

It is often said that too much of a good thing is bad. In the trademark and brand world this has a special and unique interpretation.   Read More

Earnings news from the likes of Coca-Cola, Goldman Sachs and J&J should help guide stocks Tuesday, but traders will most intently be watching the trading activity in Apple.   Read More

The "Mad Money" host reveals which earnings reports he plans to monitor.   Read More

Expect volatility in the week ahead as earnings season kicks into high gear, with 12 Dow components and nearly a fifth of the S&P 500 reporting. Plus, European sovereign debt issues.   Read More

TheStreet.com details the 10 most popular high-yielding dividend stocks among Morningstar's Ultimate Stock-Pickers funds, listed in inverse order of highest yield.   Read More